Across TCGA pan-cancer cohorts, RN7SL461P RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of RN7SL461P’s most consistent transcriptional readouts.
The strongest signal is observed in lung squamous cell carcinoma (LUSC), where RN7SL461P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RN7SL461P is over-expressed in tumor.
LUSC are the cancer types where RN7SL461P tumor–normal differential expression is most reproducible.